Taipei, Taiwan

Ko Chieh Chen

USPTO Granted Patents = 6 

Average Co-Inventor Count = 2.3

ph-index = 1

Forward Citations = 9(Granted Patents)


Location History:

  • Taichung, TW (1994)
  • Taipei, TW (2022 - 2024)

Company Filing History:


Years Active: 1994-2025

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations of Ko Chieh Chen in Pharmaceutical Compositions

Introduction

Ko Chieh Chen is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug delivery systems. With a total of six patents to his name, Chen's work focuses on enhancing the efficacy of weak acid drugs through advanced liposome compositions.

Latest Patents

One of Chen's latest patents is titled "Liposome compositions comprising weak acid drugs and uses thereof." This invention relates to a pharmaceutical composition that incorporates a weak acid drug using a bicarbonate salt, which allows for a higher drug incorporation into liposomes and improved therapeutic efficacy. Additionally, he has developed a patent for a "Pharmaceutical composition of a weak acid drug and methods of administration." This composition includes liposomes with an external lipid bilayer and an internal aqueous medium containing a weak acid drug with a short half-life. The patent also outlines methods for treating pulmonary hypertension with reduced dosing frequency.

Career Highlights

Ko Chieh Chen is associated with Pharmosa Biopharm Inc., where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing drug formulations that improve patient outcomes.

Collaborations

Chen collaborates with notable colleagues such as Pei Kan and Yi Fong Lin, contributing to a dynamic research environment that fosters innovation.

Conclusion

Ko Chieh Chen's contributions to pharmaceutical compositions demonstrate his commitment to improving drug delivery systems. His innovative patents reflect a deep understanding of pharmaceutical science and a dedication to enhancing therapeutic efficacy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…